CAD 5.21
(-0.19%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 328.19 Million CAD | 11.8% |
2022 | 293.56 Million CAD | 20.57% |
2021 | 243.47 Million CAD | 22.03% |
2020 | 199.51 Million CAD | 320.39% |
2019 | 47.46 Million CAD | 279.69% |
2018 | 12.5 Million CAD | 44.78% |
2017 | 8.63 Million CAD | 45.35% |
2016 | 5.94 Million CAD | 472.81% |
2015 | 1.03 Million CAD | 183.86% |
2014 | 365.32 Thousand CAD | 0.0% |
2013 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 95.57 Million CAD | 10.36% |
2024 Q1 | 86.6 Million CAD | 16.72% |
2023 Q2 | 89.9 Million CAD | 8.85% |
2023 FY | 328.19 Million CAD | 11.8% |
2023 Q4 | 74.19 Million CAD | -8.96% |
2023 Q3 | 81.5 Million CAD | -9.35% |
2023 Q1 | 82.59 Million CAD | 1.15% |
2022 Q2 | 75.82 Million CAD | 18.83% |
2022 FY | 293.56 Million CAD | 20.57% |
2022 Q4 | 81.65 Million CAD | 12.97% |
2022 Q3 | 72.28 Million CAD | -4.67% |
2022 Q1 | 63.8 Million CAD | 9.5% |
2021 Q2 | 65.79 Million CAD | 42.82% |
2021 Q1 | 46.06 Million CAD | -16.53% |
2021 Q4 | 58.27 Million CAD | -20.54% |
2021 FY | 243.47 Million CAD | 22.03% |
2021 Q3 | 73.34 Million CAD | 11.47% |
2020 Q2 | 53.25 Million CAD | 16.17% |
2020 FY | 199.51 Million CAD | 320.39% |
2020 Q3 | 45.23 Million CAD | -15.04% |
2020 Q4 | 55.19 Million CAD | 22.0% |
2020 Q1 | 45.83 Million CAD | 22.99% |
2019 Q2 | 3.2 Million CAD | 8.39% |
2019 Q1 | 2.95 Million CAD | -23.97% |
2019 Q4 | 37.27 Million CAD | 824.84% |
2019 FY | 47.46 Million CAD | 279.69% |
2019 Q3 | 4.03 Million CAD | 25.78% |
2018 FY | 12.5 Million CAD | 44.78% |
2018 Q4 | 3.88 Million CAD | 20.75% |
2018 Q2 | 2.23 Million CAD | -29.04% |
2018 Q1 | 3.15 Million CAD | 23.98% |
2018 Q3 | 3.22 Million CAD | 43.88% |
2017 Q3 | 1.86 Million CAD | -25.0% |
2017 Q2 | 2.48 Million CAD | 41.71% |
2017 Q1 | 1.75 Million CAD | -5.15% |
2017 FY | 8.63 Million CAD | 45.35% |
2017 Q4 | 2.54 Million CAD | 36.77% |
2016 FY | 5.94 Million CAD | 472.81% |
2016 Q1 | 1.06 Million CAD | 211.37% |
2016 Q4 | 1.84 Million CAD | -2.48% |
2016 Q2 | 1.13 Million CAD | 6.27% |
2016 Q3 | 1.89 Million CAD | 66.7% |
2015 Q3 | 114 Thousand CAD | -65.73% |
2015 Q4 | 343 Thousand CAD | 200.88% |
2015 FY | 1.03 Million CAD | 183.86% |
2015 Q1 | 247.35 Thousand CAD | 125.67% |
2015 Q2 | 332.67 Thousand CAD | 34.49% |
2014 Q4 | 109.6 Thousand CAD | 1488.29% |
2014 Q3 | 6901.00 CAD | -97.21% |
2014 Q2 | 247.37 Thousand CAD | 17066.76% |
2014 Q1 | 1441.00 CAD | 0.0% |
2014 FY | 365.32 Thousand CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q3 | 1.56 Million CAD | 0.0% |
2012 Q3 | 463.12 Thousand CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aurora Cannabis Inc. | 270.28 Million CAD | -21.429% |
Avicanna Inc. | 16.79 Million CAD | -1854.556% |
Avant Brands Inc. | 26.34 Million CAD | -1145.821% |
Cardiol Therapeutics Inc. | - CAD | -Infinity% |
Crescita Therapeutics Inc. | 17.52 Million CAD | -1773.068% |
MediPharm Labs Corp. | 33.06 Million CAD | -892.677% |
OrganiGram Holdings Inc. | 149.2 Million CAD | -119.965% |
Canopy Growth Corporation | 297.14 Million CAD | -10.45% |
Willow Biosciences Inc. | 1.17 Million CAD | -27903.328% |
Auxly Cannabis Group Inc. | 101.07 Million CAD | -224.699% |